NCT07108725 Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction
| NCT ID | NCT07108725 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The General Authority for Teaching Hospitals and Institutes |
| Condition | Non-invasive Diffusion-weighted Imaging |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-05-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the diagnostic value of non-invasive diffusion-weighted magnetic resonance imaging (DW-MRI) in detecting neoplastic biliary obstruction.
Eligibility Criteria
Inclusion Criteria: * Adult patients (≥18 years) with clinically suspected biliary obstruction (e.g., jaundice, elevated liver enzymes, cholestasis). * Patients who are scheduled for magnetic resonance cholangiopancreatography (MRCP) and have undergone conventional imaging \[ultrasound or computed tomography (CT)\]. * Patients who will undergo further invasive procedures, e.g., endoscopic retrograde cholangiopancreatography (ERCP), biopsy. Exclusion Criteria: * Patients with contraindications to magnetic resonance imaging (MRI) (e.g., pacemakers, metal implants). * Patients who have previously undergone major biliary surgery or stent placement. * Pregnant or lactating women.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07108725 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-invasive Diffusion-weighted Imaging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07108725 currently recruiting?
Yes, NCT07108725 is actively recruiting participants. Contact the research team at hekmattsamir@gmail.com for enrollment information.
Where is the NCT07108725 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07108725 clinical trial?
NCT07108725 is sponsored by The General Authority for Teaching Hospitals and Institutes. The trial plans to enroll 100 participants.